Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-09

Clinical Trial Update: Liposomal Bupivacaine Intercostal Nerve Block vs Thoracic Epidural for Regional Analgesia in Multiple Rib Fractures [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing liposomal bupivacaine intercostal nerve block to thoracic epidural for regional analgesia in patients with multiple rib fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • liposomal bupivacaine intercostal nerve block (liposomal bupivacaine)
  • thoracic epidural

Snippet

Sponsor: Chadrick Evans | Conditions: Trauma, Trauma Injury | Phase 4 | Status: UNKNOWN